Superior Mesenteric Artery Syndrome

SMA syndrome is a rare (incidence 0.013%–0.3%) but potentially life-threatening cause of duodenal obstruction resulting from compression of the third portion of the duodenum between the SMA anteriorly and the aorta/vertebral column posteriorly, due to a narrowed aortomesenteric angle (<25°) and distance (<10 mm).[1-2] It predominantly affects young females (F:M = 3:2), ages 10–39, and is most commonly precipitated by rapid weight loss.[1][3]

1. History

• Key HPI questions: Onset and duration of postprandial epigastric pain, nausea, vomiting (especially bilious), early satiety, and weight loss[1][4]
• Symptom characterization: Epigastric fullness, crampy postprandial pain, voluminous or bilious emesis; symptoms typically worsen with eating and lying supine[1][5]
• Timing/triggers: Postprandial exacerbation; supine position worsens symptoms (decreases aortomesenteric angle); relief with prone, knee-to-chest, or left lateral decubitus positioning[1]
• Progression: Quantify weight loss (amount and timeline); ask about recent surgery, immobilization, body casting, or spinal procedures[1][6]
• Important negatives: Absence of bloody emesis, melena, fever, prior abdominal surgery, or history of inflammatory bowel disease

2. Alarm Features

• Bilious vomiting with inability to tolerate any oral intake — suggests complete or near-complete obstruction
• Severe dehydration and electrolyte derangements (hypokalemia, metabolic alkalosis from protracted vomiting)[7]
• Acute gastric dilation — can progress to gastric necrosis, perforation, or aspiration[8]
• Signs of bowel ischemia — severe constant pain, peritoneal signs, hemodynamic instability
• Portal venous gas or gastric wall pneumatosis on imaging — rare but catastrophic complications[9]
• Massive weight loss with BMI <15 kg/m² — high risk for refeeding syndrome during nutritional rehabilitation

3. Medications

Symptomatic treatment

• Antiemetics: ondansetron (5-HT₃ antagonist), prochlorperazine, or promethazine for nausea/vomiting[10-11]
• Metoclopramide 10 mg IV/PO q6–8h — prokinetic and antiemetic; limit use to ≤12 weeks due to risk of tardive dyskinesia[10][12]
• PPIs (e.g., omeprazole, pantoprazole) — for gastric acid suppression and prevention of stress/stasis ulceration[5][13]
• Medications to avoid: Anticholinergics and opioids (worsen gastric motility and may exacerbate obstruction)
• Cautions: Metoclopramide is contraindicated in complete mechanical obstruction[14]

4. Diet

• Acute phase: NPO with nasogastric decompression if significant gastric dilation; transition to nasojejunal (NJ) tube feeds past the obstruction, or TPN if enteral access is not feasible[1][15]
• Subacute/chronic: Small, frequent, high-calorie meals; positional eating (left lateral decubitus or prone during and after meals) to open the aortomesenteric angle[1]
• Long-term goal: Caloric surplus to restore retroperitoneal and mesenteric fat pad, thereby widening the aortomesenteric angle[1][16]
• Hydration: Aggressive IV fluid resuscitation initially; monitor for refeeding syndrome (phosphate, magnesium, potassium) in severely malnourished patients

5. Review of Systems

• GI: Nausea, vomiting (bilious?), abdominal distension, early satiety, anorexia, constipation, reflux symptoms
• Constitutional: Weight loss (quantify), fatigue, weakness
• Psychiatric: Screen for eating disorders (anorexia nervosa, bulimia, ARFID) — SMA syndrome and eating disorders frequently coexist and can mask each other[17-19]
• Musculoskeletal: Recent spinal surgery, body casting, scoliosis correction, back brace use[6]
• Neurologic: Spinal cord injury, prolonged immobilization, ALS or other neurodegenerative conditions[20]

6. Collateral History and Family History

• Collateral: Corroborate weight loss timeline, dietary habits, and eating behaviors from family/caregivers; assess for concealed eating disorder behaviors (food restriction, purging)[19]
• Family history: Rare familial cases have been reported, including in monozygotic twins; ask about family members with similar GI symptoms or known SMA syndrome[1][5]
• Social context: Military training (rapid weight loss from physical stress), athletic training, psychosocial stressors contributing to weight loss[9]

7. Risk Factors

• Rapid or significant weight loss (most common acquired cause)[1][21]
• Eating disorders: Anorexia nervosa, bulimia, ARFID[17-18][22]
• Low BMI (median BMI ~17.8 kg/m² in surgical series)[3]
• Postoperative states: Spinal surgery (0.5%–2.4% incidence), bariatric surgery, esophagectomy, proctocolectomy, Nissen fundoplication[1][6]
• Prolonged immobilization/bed rest: Trauma, burns, spinal cord injury, body casting ("cast syndrome")[1]
• Severe debilitating illness: Malignancy, HIV/AIDS, CHF, malabsorption syndromes[1]
• Congenital anatomic variants: Low SMA takeoff, short mesenteric root, duodenal malrotation, high ligament of Treitz[1]
• Spinal deformity: Hyperlordosis, scoliosis (traction on mesentery)[6]

8. Differential Diagnosis

• Gastroparesis — delayed emptying without fixed anatomic obstruction; distinguished by gastric emptying study
• Small bowel obstruction (adhesive, hernia, tumor) — CT shows transition point not at SMA crossing
• Duodenal web or atresia — congenital intrinsic obstruction; may mimic SMA syndrome on UGI[23]
• Annular pancreas — congenital duodenal compression; CT/MRCP distinguishes
• Peptic ulcer disease with duodenal stricture — endoscopy reveals ulceration/scarring[13]
• Malrotation with Ladd bands — UGI shows abnormal duodenojejunal junction position
• Eating disorder without true SMA syndrome — radiologic findings of narrowed angle may be incidental in cachectic patients; clinical correlation essential[17]
• Functional dyspepsia — diagnosis of exclusion; most common initial clinical impression before SMA syndrome is identified[24]
• Pancreatitis/cholecystitis — can cause secondary duodenal compression[1]
• Mesenteric root mass/lymphadenopathy — extrinsic compression visible on CT[23]

9. Past Medical History

• Prior episodes of similar symptoms (SMA syndrome can be chronic/intermittent)[13]
• History of eating disorders or psychiatric illness[19]
• Previous abdominal or spinal surgeries[1][6]
• Chronic illnesses causing cachexia (malignancy, HIV, IBD, malabsorption)
• Connective tissue disorders (Ehlers-Danlos, Marfan — associated with visceral ptosis)
• Prior neurologic injury (spinal cord injury, ALS)[20]

10. Physical Exam

• Vitals: Tachycardia, orthostatic hypotension (dehydration); low BMI
• General: Cachectic or thin habitus; assess nutritional status

Abdomen

• Epigastric distension and tenderness
• Succussion splash (retained gastric contents)
• High-pitched bowel sounds proximal to obstruction
• Hayes maneuver: Pressure applied to infraumbilical region, lifting cephalad and dorsally — temporary symptom relief supports diagnosis[1]
• Positional relief: Symptoms improve in prone, knee-to-chest, or left lateral decubitus position[1]
• Concerning findings: Peritoneal signs (rigidity, rebound) suggest perforation or ischemia; absent bowel sounds suggest ileus

11. Lab Studies

• BMP/CMP: Electrolytes (hypokalemia, hypochloremia, metabolic alkalosis from vomiting), BUN/Cr (dehydration), glucose
• CBC: Leukocytosis (if complicated by perforation/infection)
• Hepatic panel: Elevated transaminases may indicate malnutrition[18]
• Lipase/amylase: Rule out pancreatitis
• Prealbumin, albumin: Nutritional status markers
• Phosphate, magnesium: Baseline before refeeding (refeeding syndrome risk)
• Lactate: If concern for bowel ischemia
• Urinalysis: Assess hydration, ketones (starvation ketosis)

12. Imaging

• First-line: Contrast-enhanced CT abdomen/pelvis — current standard for diagnosis[1-2][25]
• Demonstrates reduced aortomesenteric angle (<25°, diagnostic range 6°–22°) and aortomesenteric distance (<10 mm, often 2–8 mm)[1][25-26]
• Shows gastric and proximal duodenal dilation with abrupt narrowing at the third portion of the duodenum
• Normal values: angle 38°–65°, distance 10–28 mm[1]
• Upper GI series with barium/contrast — shows exact location of duodenal impingement, delayed transit, and positional obstruction on fluoroscopy[1][4][27]
• Ultrasound (including POCUS) — can measure aortomesenteric angle and distance; useful in the ED and for radiation-sparing evaluation[27-28]
• MR angiography — alternative for radiation-sensitive patients (pediatric, young adults)[1]
• Plain radiograph (KUB) — may show enlarged gastric bubble and dilated proximal duodenum; low sensitivity[1]
• When imaging is unnecessary: Mild, self-limited postprandial symptoms without weight loss or alarm features

13. Special Tests

• Endoscopy (EGD): Can reveal pulsating vertical/oblique band at D3, slit-like luminal narrowing, proximal duodenal dilation, and bile lake in the stomach — suggestive triad[24]
• POCUS in the ED: Measurement of aortomesenteric angle and distance can expedite diagnosis[28]
• Gastric emptying study: To differentiate from gastroparesis if diagnosis is uncertain
• CT angiography with 3D reconstruction: Sagittal MIP images reliably demonstrate decreased angle and distance[25]

14. ECG

• Indications: Obtain ECG in patients with significant vomiting, electrolyte derangements, or severe malnutrition

Findings to watch for

• Hypokalemia: U waves, flattened T waves, ST depression, prolonged QT
• Hypomagnesemia: Prolonged QT, torsades risk
• Severe malnutrition/eating disorders: Bradycardia, prolonged QTc, arrhythmias

15. Assessment

• SMA syndrome is a diagnosis of exclusion that requires clinical-radiographic correlation — narrowed aortomesenteric angle alone is insufficient without compatible symptoms[2][27]

Severity stratification

• Mild/intermittent: Postprandial symptoms with positional relief, tolerating some oral intake
• Moderate: Significant weight loss, frequent vomiting, unable to maintain nutrition orally
• Severe: Complete obstruction, acute gastric dilation, electrolyte crisis, hemodynamic instability
• Typical presentation: Young, thin female with recent weight loss, postprandial epigastric pain, bilious vomiting, and early satiety[1][3]
• Atypical presentations: Older adults, post-surgical patients, patients without significant weight loss, congenital variants[4][20]
• Complications: Dehydration, electrolyte abnormalities, aspiration pneumonia, gastric perforation/necrosis, portal venous gas, refeeding syndrome during treatment[7-9]

16. Treatment Plan

Initial stabilization (ED)

• NPO and nasogastric tube decompression for gastric dilation
• IV fluid resuscitation with electrolyte correction (potassium, magnesium, phosphate)
• Antiemetics (ondansetron 4 mg IV, metoclopramide 10 mg IV if partial obstruction)
• Positional therapy: Left lateral decubitus or prone positioning[1]

Conservative management (first-line)

• Nutritional rehabilitation is the cornerstone — goal is weight gain to restore mesenteric/retroperitoneal fat and widen the aortomesenteric angle[1][15]
• NJ tube feeds past the obstruction, or TPN if enteral access fails[1][21]
• Small, frequent, high-calorie meals when tolerating oral intake
• PPI for gastroprotection
• Enteral nutrition therapy showed symptom resolution in 65% and improvement in an additional 15% of patients in one series[15]

Surgical management (for refractory cases)

• Indicated when conservative management fails (typically after weeks to months of nutritional therapy)[1-2]
• Laparoscopic duodenojejunostomy — procedure of choice; median hospital stay 5–6 days; long-term symptom resolution in ~79%–86%[29-31]
• Strong procedure (division of ligament of Treitz) — avoids anastomosis but has a 25% failure rate[1]
• Gastrojejunostomy — alternative but does not relieve proximal duodenal obstruction[1]

17. Disposition

Admit if

• Unable to tolerate oral intake
• Significant dehydration or electrolyte abnormalities
• Bilious vomiting with evidence of obstruction on imaging
• Severe malnutrition requiring NJ feeds or TPN
• Concern for complications (gastric dilation, perforation, aspiration)
• Observation may be appropriate for mild/intermittent symptoms with adequate oral tolerance after ED rehydration
• Discharge criteria: Tolerating oral intake, electrolytes corrected, reliable follow-up arranged

Consult triggers

• General surgery — for all confirmed cases (early involvement recommended)[16]
• Gastroenterology — for endoscopic evaluation and nutritional planning
• Nutrition/dietetics — for caloric optimization
• Psychiatry — if eating disorder is suspected or confirmed[17][19]
• Multidisciplinary approach (GI, vascular, radiology, surgery) is recommended[16]

18. Follow Up / Return Precautions

• Follow-up timing: GI and/or surgery follow-up within 1–2 weeks of discharge; serial weight monitoring
• Return precautions — instruct patients to return immediately for:
• Inability to keep down any fluids
• Worsening or severe abdominal pain
• Bilious or bloody vomiting
• Dizziness, fainting, or signs of dehydration
• Abdominal rigidity or distension

Patient counseling

• Positional eating strategies (sit upright or left lateral during/after meals)
• Small, frequent, calorie-dense meals
• Importance of weight gain for symptom resolution
• If eating disorder is present, ongoing psychiatric/psychological support is essential[18-19]
• Expected recovery: Most patients respond to conservative nutritional management; surgical patients typically recover within days with excellent long-term outcomes (no recurrence in 86% at mean 41-month follow-up)[30]
• Monitoring: Serial imaging (CT or UGI) and nutritional labs (prealbumin, electrolytes) to track response[5][15]

References

1. Laparoscopic Management of Duodenal Obstruction Resulting From Superior Mesenteric Artery Syndrome. — Pottorf BJ, Husain FA, Hollis HW, Lin E. JAMA Surgery. 2014.

2. Superior Mesenteric Artery Syndrome and Its Associated Gastrointestinal Implications. — Mathenge N, Osiro S, Rodriguez II, et al. Clinical Anatomy. 2014.

3. Superior Mesenteric Artery Syndrome: A Prospective Study in a Single Institution. — Ganss A, Rampado S, Savarino E, Bardini R. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract. 2019.

4. Superior Mesenteric Artery Syndrome in Children: A 20-Year Experience. — Biank V, Werlin S. Journal of Pediatric Gastroenterology and Nutrition. 2006.

5. Possible Familial Predisposition in Superior Mesenteric Artery Syndrome With Surgical Management: A Case Report. — Maraqah M, Al Tamimi MF, Abu Aram S, et al. Medicine. 2025.

6. Relief of Superior Mesenteric Artery Syndrome With Correction of Multiplanar Spinal Deformity by Posterior Spinal Fusion. — Marecek GS, Barsness KA, Sarwark JF. Orthopedics. 2010.

7. Recurrent Superior Mesenteric Artery Syndrome Complicating Staged Reconstructive Spinal Surgery: Alternative Methods of Conservative Treatment. — Walker C, Kahanovitz N. Journal of Pediatric Orthopedics. 1983.

8. The Superior Mesenteric Artery Syndrome and Acute Gastric Dilatation in Eating Disorders: A Report of Two Cases and a Review of the Literature. — Adson DE, Mitchell JE, Trenkner SW. The International Journal of Eating Disorders. 1997.

9. Superior Mesenteric Artery Syndrome in a Young Military Basic Trainee. — Schauer SG, Thompson AJ, Bebarta VS. Military Medicine. 2013.

10. Evaluation and Treatment of Nausea and Vomiting in Adults. — Johns T, Lawrence E. American Family Physician. 2024.

11. AGA Clinical Practice Update on Management of Medically Refractory Gastroparesis: Expert Review. — Lacy BE, Tack J, Gyawali CP. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association. 2022.

12. Review article: treatment options for functional dyspepsia. — Masuy I, Van Oudenhove L, Tack J. Alimentary Pharmacology & Therapeutics. 2019.

13. Superior Mesenteric Artery Syndrome Complicated With Duodenal Bulb-Descending Ulcerative Stricture: A Case Report and Literature Review. — Yang E, Zhang J, Yang Z, et al. Frontiers in Medicine. 2025.

14. Brazilian Society of Surgical Oncology guidelines for malignant bowel obstruction management. — Zanatto RM, Lisboa CN, de Oliveira JC, et al. Journal of Surgical Oncology. 2022.

15. Superior Mesenteric Artery Syndrome Improved by Enteral Nutritional Therapy: A Retrospective Case-Series Study in a Single Institution. — Wan S, Zhang L, Yang J, Gao X, Wang X. Annals of Nutrition & Metabolism. 2020.

16. Superior Mesenteric Artery Syndrome: A Single Centre Experience of Laparoscopic Duodenojejunostomy as the Operation of Choice. — Kirby GC, Faulconer ER, Robinson SJ, Perry A, Downing R. Annals of the Royal College of Surgeons of England. 2017.

17. An Eating Disorder Disguised as Superior Mesenteric Artery Syndrome. — Hundman C, Bowden M, Landisch R, Edwards P, Rogers N. Journal of the National Medical Association. 2025.

18. The Intersection Between Eating Disorders and Gastrointestinal Disorders: A Narrative Review and Practical Guide. — Staller K, Abber SR, Burton Murray H. The Lancet. Gastroenterology & Hepatology. 2023.

19. Delayed Diagnosis of an Eating Disorder in a Male Patient With Superior Mesenteric Artery Syndrome: Results From a Case Study. — Recio-Barbero M, Fuertes-Soriano S, Cabezas-Garduño J, et al. Frontiers in Psychiatry. 2019.

20. Minimal Weight Loss Related to a Short Fasting Period Causes Superior Mesenteric Artery Syndrome in a Patient With Amyotrophic Lateral Sclerosis: A Case Report. — Kang DH, Baik SW, Won YH, Ko MH. Medicine. 2020.

21. Superior Mesenteric Artery Syndrome in a 16-Year-Old With Bilious Emesis. — Kurbegov A, Grabb B, Bealer J. Current Opinion in Pediatrics. 2010.

22. Minimally Invasive Surgery for Superior Mesenteric Artery Syndrome: A Case Report. — Yao SY, Mikami R, Mikami S. World Journal of Gastroenterology. 2015.

23. Duodenojejunal Junction Web Masquerading as Wilkie's Syndrome: Report of a Case. — Basu S, Srivastava V, Singh PK, Srivastava A, Shukla VK. Surgery Today. 2011.

24. Endoscopic Features for Early Decision to Evaluate Superior Mesenteric Artery Syndrome in Children. — Kim JY, Shin MS, Lee S. BMC Pediatrics. 2021.

25. Multidetector Row CT of Superior Mesenteric Artery Syndrome. — Agrawal GA, Johnson PT, Fishman EK. Journal of Clinical Gastroenterology. 2007.

26. An Uncommon Case of Abdominal Pain: Superior Mesenteric Artery Syndrome. — Felton BM, White JM, Racine MA. The Western Journal of Emergency Medicine. 2012.

27. Superior Mesenteric Artery Syndrome: A Radiographic Review. — Warncke ES, Gursahaney DL, Mascolo M, Dee E. Abdominal Radiology. 2019.

28. Point-of-Care Ultrasound Findings in the Diagnosis and Management of Superior Mesenteric Artery (SMA) Syndrome. — Le D, Stirparo JJ, Magdaleno TF, Paulson CL, Roth KR. The American Journal of Emergency Medicine. 2022.

29. Wilkie's Syndrome: Laparoscopic Duodenojejunostomy. — Bozzetti M, Romei B, Leszczynski J, et al. Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A. 2026.

30. SMA Syndrome: Management Perspective With Laparoscopic Duodenojejunostomy and Long-Term Results. — Jain N, Chopde A, Soni B, et al. Surgical Endoscopy. 2021.

31. Minimally Invasive Duodenojejunostomy for Superior Mesenteric Artery Syndrome: A Case Series and Review of the Literature. — Sun Z, Rodriguez J, McMichael J, et al. Surgical Endoscopy. 2015.